Cargando…

SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice

Background: The role of the cAMP/PKA signaling in molecular pathways involved in fear memory is well established: PKA is required for fear memory formation and is a constraint for fear extinction. Previously we reported that a Prkar1a heterozygote (HZ) mouse that was developed in our lab to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Keil, Margaret, Paradiso, Enrica, Keil, Rita S, Ugolini, Maddalena, Harris, Evan, Wu, T John, Stratakis, Constantine A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209467/
http://dx.doi.org/10.1210/jendso/bvaa046.1855
_version_ 1783531084725616640
author Keil, Margaret
Paradiso, Enrica
Keil, Rita S
Ugolini, Maddalena
Harris, Evan
Wu, T John
Stratakis, Constantine A
author_facet Keil, Margaret
Paradiso, Enrica
Keil, Rita S
Ugolini, Maddalena
Harris, Evan
Wu, T John
Stratakis, Constantine A
author_sort Keil, Margaret
collection PubMed
description Background: The role of the cAMP/PKA signaling in molecular pathways involved in fear memory is well established: PKA is required for fear memory formation and is a constraint for fear extinction. Previously we reported that a Prkar1a heterozygote (HZ) mouse that was developed in our lab to investigate Carney complex (CNC), the disease caused by PRKAR1A mutations, showed brain region-specific increased PKA activity that was associated with anxiety-like behavioral phenotype and threat bias (Keil, 2010, 2013). We hypothesized that Prkar1a(+/-) (HZ) mice would have deficits in fear extinction behavior. Brain derived neurotrophic factor (BDNF) has a critical role in formation of fear memory and its transcription is regulated by PKA/CREB. A mouse model with down regulation of PKA provides an opportunity for the first time to investigate the effect of altered PKA signaling on fear conditioning and extinction. Method: Fear conditioning, fear extinction learning, and fear extinction recall were tested in adult male HZ and wild-type (WT) mice as follows: fear conditioning training followed 24hr later by extinction training (new context), then 24hr later by extinction recall training. Percentage of time freezing was used to assess conditioned fear response. We measured BDNF gene expression in brain regions after completion of extinction recall training. Results: As expected, fear conditioning (learning) behavior was similar in HZ and WT mice. However, HZ mice showed a significant deficit in the early phase of fear extinction learning compared to WT. There was no difference in extinction recall between genotypes. Alterations in BDNF gene expression in the prefrontal cortex and amygdala was associated with deficit in fear extinction. Conclusion: Mice with a downregulation of Prkar1a gene demonstrate intact fear conditioning but impaired fear extinction learning, consistent with prior studies that report that PKA inhibition is necessary to facilitate extinction learning. Prkar1a(+/-) mice provide a valuable model to investigate impaired fear extinction to identify mechanisms for therapeutic targets for anxiety and trauma-related disorders.
format Online
Article
Text
id pubmed-7209467
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72094672020-05-13 SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice Keil, Margaret Paradiso, Enrica Keil, Rita S Ugolini, Maddalena Harris, Evan Wu, T John Stratakis, Constantine A J Endocr Soc Neuroendocrinology and Pituitary Background: The role of the cAMP/PKA signaling in molecular pathways involved in fear memory is well established: PKA is required for fear memory formation and is a constraint for fear extinction. Previously we reported that a Prkar1a heterozygote (HZ) mouse that was developed in our lab to investigate Carney complex (CNC), the disease caused by PRKAR1A mutations, showed brain region-specific increased PKA activity that was associated with anxiety-like behavioral phenotype and threat bias (Keil, 2010, 2013). We hypothesized that Prkar1a(+/-) (HZ) mice would have deficits in fear extinction behavior. Brain derived neurotrophic factor (BDNF) has a critical role in formation of fear memory and its transcription is regulated by PKA/CREB. A mouse model with down regulation of PKA provides an opportunity for the first time to investigate the effect of altered PKA signaling on fear conditioning and extinction. Method: Fear conditioning, fear extinction learning, and fear extinction recall were tested in adult male HZ and wild-type (WT) mice as follows: fear conditioning training followed 24hr later by extinction training (new context), then 24hr later by extinction recall training. Percentage of time freezing was used to assess conditioned fear response. We measured BDNF gene expression in brain regions after completion of extinction recall training. Results: As expected, fear conditioning (learning) behavior was similar in HZ and WT mice. However, HZ mice showed a significant deficit in the early phase of fear extinction learning compared to WT. There was no difference in extinction recall between genotypes. Alterations in BDNF gene expression in the prefrontal cortex and amygdala was associated with deficit in fear extinction. Conclusion: Mice with a downregulation of Prkar1a gene demonstrate intact fear conditioning but impaired fear extinction learning, consistent with prior studies that report that PKA inhibition is necessary to facilitate extinction learning. Prkar1a(+/-) mice provide a valuable model to investigate impaired fear extinction to identify mechanisms for therapeutic targets for anxiety and trauma-related disorders. Oxford University Press 2020-05-08 /pmc/articles/PMC7209467/ http://dx.doi.org/10.1210/jendso/bvaa046.1855 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Keil, Margaret
Paradiso, Enrica
Keil, Rita S
Ugolini, Maddalena
Harris, Evan
Wu, T John
Stratakis, Constantine A
SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice
title SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice
title_full SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice
title_fullStr SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice
title_full_unstemmed SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice
title_short SUN-235 Deficient Fear Extinction in PRKAR1A-Defective Mice
title_sort sun-235 deficient fear extinction in prkar1a-defective mice
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209467/
http://dx.doi.org/10.1210/jendso/bvaa046.1855
work_keys_str_mv AT keilmargaret sun235deficientfearextinctioninprkar1adefectivemice
AT paradisoenrica sun235deficientfearextinctioninprkar1adefectivemice
AT keilritas sun235deficientfearextinctioninprkar1adefectivemice
AT ugolinimaddalena sun235deficientfearextinctioninprkar1adefectivemice
AT harrisevan sun235deficientfearextinctioninprkar1adefectivemice
AT wutjohn sun235deficientfearextinctioninprkar1adefectivemice
AT stratakisconstantinea sun235deficientfearextinctioninprkar1adefectivemice